Skip to content
Aptadel Therapeutics logo — Aptadel Therapeutics is a biotech company focused on the dev...

Aptadel Therapeutics

Aptadel Therapeutics is a biotech company focused on the development of cancer treatment based on aptamer technology.

Founded 2020 Spain Spain 7 employees Seed Total: $1.70M Biotechnology, Health Care

General Information

Company Name Aptadel Therapeutics
Founded Year 2020
Location Spain Spain
Founders / Decision Makers
Team member
Employees 7
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Aptadel Therapeutics. To contact Aptadel Therapeutics, visit aptadeltx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aptadel Therapeutics compare?

A PDF of Aptadel Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aptadel Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aptadel Therapeutics

Aptadel Therapeutics is a preclinical-stage biotech company based in Barcelona, Spain with a strong focus on developing cancer treatments utilizing aptamer technology. The company's lead indication is Ewing Sarcoma, a rare form of bone cancer primarily affecting children. Established in 2020, Aptadel Therapeutics recently received a €1.70M investment in a Seed Round, with Alba Pérez Foundation being the lead investor, marking a significant milestone. This biotech startup operates in the Biotechnology and Health Care industries with a goal to revolutionize cancer treatment through its RNA-based delivery platform. With its innovative approach and dedicated team, Aptadel Therapeutics stands at the forefront of the biotech sector, aiming to make a positive impact on cancer therapy.

Business keywords: Biotech company, Cancer treatment, Aptamer technology, RNA-based delivery platform, Preclinical-stage, Barcelona, Spain, Ewing Sarcoma, Rare cancer, Children's cancer, Biomedical company, Targeted therapy, Preclinical research, RNA-based platform, Aptadel Therapeutics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €1.70M 1
Alba Pérez Foundation
21 Jan 2021

Aptadel Therapeutics Alternatives & Competitors

View All Alternatives
Aptadel Therapeutics vs

Delivering a cancer-free future

Post-IPO Equity
11 employees
Biotechnology, Health Care
Aptadel Therapeutics vs

Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer using an “In...

Angel
1 employees
Biotechnology, Health Care
Aptadel Therapeutics vs

Programmable Therapeutics for Causal Biology - Science Guides Us. The Genome Powers Us. Patients Gr...

68 employees
Biopharma, Biotechnology

FAQ About Aptadel Therapeutics

Aptadel Therapeutics is a biotech company focused on the development of cancer treatment based on aptamer technology.
Aptadel Therapeutics was founded in 2020.
Aptadel Therapeutics is headquartered in Spain.
Aptadel Therapeutics operates in Biotechnology and Health Care. Its work centres on Biotech company, Cancer treatment, Aptamer technology and RNA-based delivery platform.
Aptadel Therapeutics has approximately 7 employees.
Aptadel Therapeutics has completed 1 funding round, raising a total of $1.70M. The latest funding stage is Seed.
Top alternatives and competitors to Aptadel Therapeutics include TransCode Therapeutics, Inc., Novelogics Biotechnology Inc., HAYA Therapeutics, OncXerna Therapeutics , SiSaf Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aptadel Therapeutics and TransCode Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aptadel Therapeutics, https://bouncewatch.com/company/aptadel-therapeutics, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout